General
Preferred name
LANPERISONE
Synonyms
Lanperisone hydrochloride ()
NK 433 ()
Lanperisone (hydrochloride) ()
NK433 ()
Lanperisone HCl ()
Lanperisona ()
P&D ID
PD014615
CAS
116287-14-0
116287-13-9
Tags
available
drug candidate
Drug indication
Musculoskeletal disorder
Drug Status
investigational
Max Phase
2.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE
795
DESCRIPTION
Lanperisone HCl (NK 433) is a novel orally available centrally acting muscle relaxant with anticancer activity and inhibits mono- and polysynaptic reflex potentials.Lanperisone HCl acts by inducing non-apoptotic cell death in the cell cycle and translational independence.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
1
Organisms
0
Compound Sets
5
ChEMBL Drugs
DrugMAP
MedChem Express Bioactive Compound Library
NPC Screening Collection
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
24
Molecular Weight
285.13
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
0
Rotatable Bonds
4
Ring Count
2
Aromatic Ring Count
1
cLogP
3.62
TPSA
20.31
Fraction CSP3
0.53
Chiral centers
1.0
Largest ring
6.0
QED
0.79
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
Apoptosis
Source data
